RxDoctor Payments Data

Robert Abady, DPM

Foot & Ankle Surgery · Saint Petersburg, FLNPI 1598767907

Payments from drug & device makers

$15,182in general payments, 2019–2025

Across 216 payments — averaging $70.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Skye Orthobiologics LLC$5K
  • Smith+Nephew$4K
  • Integra Lifesciences Corporation$2K
  • Acumed LLC$680
  • Progenacare Global, LLC$609
  • Paratek Pharmaceuticals, Inc.$469
  • plus $3K from 30 others
$2,250in research payments, 2019–2025

Across 1 payment — averaging $2250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Skye Orthobiologics LLC$2K

What the payments were for

  • Consulting fees$1161%
  • Travel & lodging$1,91019%
  • Food & beverage$7,90780%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,182 in reported general payments places this provider in the 80th percentile of 850 foot & ankle surgery providers in Florida.

See all foot & ankle surgery providers in Florida

Medicare billing

Part B allowed, 2024
$54,585
Medicare patients
155
Services billed
693

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Calcipotriene19$2,617
Allopurinol26$243
Celecoxib11$131
Methylprednisolone11$94
Cephalexin15$69

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Saint Petersburg

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →